University Of Notre Dame Du Lac decreased its stake in Sage Therapeutics Inc (SAGE) by 22.14% based on its latest 2019Q1 regulatory filing with the SEC. University Of Notre Dame Du Lac sold 4,645 shares as the company’s stock rose 5.98% with the market. The institutional investor held 16,334 shares of the health care company at the end of 2019Q1, valued at $2.60 million, down from 20,979 at the end of the previous reported quarter. University Of Notre Dame Du Lac who had been investing in Sage Therapeutics Inc for a number of months, seems to be less bullish one the $8.83 billion market cap company. The stock decreased 1.82% or $3.2 during the last trading session, reaching $172.64. About 214,761 shares traded. Sage Therapeutics, Inc. (NASDAQ:SAGE) has declined 2.09% since June 11, 2018 and is downtrending. It has underperformed by 6.52% the S&P500. Some Historical SAGE News: 30/04/2018 – LEBARA SAYS NEW CFO OLIVIER SAGE WILL JOIN FROM MID MAY; 02/05/2018 – Sage culls senior executives to simplify operations; 02/05/2018 – Sage Group 1H EPS 12.48p; 13/04/2018 – Sage Group: Rolling Mid-Term Guidance Remains for 10% Organic Revenue Growth; 14/03/2018 – DELOS CAPITAL BUYS SAGE METALS LIMITED; 15/05/2018 – Five Leaders Across Sage Named CRN’s 2018 Women of the Channel; 27/04/2018 – Sage Gold – Commences Extraction – 175E Stope; 02/05/2018 – Sage Group 1H Pre-items, Pretax Pft GBP208M; 27/04/2018 – SAGE GOLD INC – HAS BEEN LATE IN PREPARATION OF ANNUAL FILINGS DUE TO TRANSITION ISSUES FOLLOWING CHANGE OF CHIEF FINANCIAL OFFICER IN NOVEMBER 2017; 18/04/2018 – Sage Intacct and GuideStar Improve Financial Health & Sustainability for Nonprofit Organizations with Innovative Dashboard
Valueworks Llc increased its stake in Apple Inc (AAPL) by 19.75% based on its latest 2019Q1 regulatory filing with the SEC. Valueworks Llc bought 7,118 shares as the company’s stock rose 12.19% with the market. The institutional investor held 43,160 shares of the computer manufacturing company at the end of 2019Q1, valued at $8.20M, up from 36,042 at the end of the previous reported quarter. Valueworks Llc who had been investing in Apple Inc for a number of months, seems to be bullish on the $886.08 billion market cap company. The stock increased 1.28% or $2.43 during the last trading session, reaching $192.58. About 26.22 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 1.47% since June 11, 2018 and is uptrending. It has underperformed by 2.96% the S&P500. Some Historical AAPL News: 17/05/2018 – Apple may be the only company that can push the health-care industry into the future; 01/05/2018 – Apple Sees 3Q Rev $51.5B-$53.5B; 07/03/2018 – Macworld: iPad 2018 rumors: New iPad Pro design with Face ID to launch at WWDC in June; 14/03/2018 – France to sue Apple and Google over developer fees; 30/04/2018 – Apple loses top slot of India’s premium smartphone market to Samsung; 01/05/2018 – Apple CEO Tim Cook takes a victory lap as China revenue rockets on strength of iPhone X; 12/04/2018 – VirnetX Confirms $502.6 Million Award From Patent Case Win Against Apple — MarketWatch; 23/04/2018 – Billboard: Apple Plans for Nashville Expansion as Jay Liepis Moves to Music City; 25/05/2018 – Volkswagen to Join Apple For Autonomous Project; 03/05/2018 – The company’s core wearable fitness trackers business has fallen sharply as it faces bigger names with deeper pockets, such as Apple and Samsung
More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Seekingalpha.com which released: “Apple’s Buybacks Provide Strong Long-Term Upside – Seeking Alpha” on May 14, 2019, also Nasdaq.com with their article: “Noteworthy ETF Inflows: IWF, AAPL, UNH, BA – Nasdaq” published on June 03, 2019, Livetradingnews.com published: “The rally in Apple Inc. (NASDAQ:AAPL) stock has faded, and rising risks should add to the pressure – Live Trading News” on May 16, 2019. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Nasdaq.com and their article: “Technology Sector Update for 06/05/2019: PVTL, GME, AMBA, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” published on June 05, 2019 as well as Nasdaq.com‘s news article titled: “Friday Apple Rumors: iOS 13 Helps Filter Spam Calls – Nasdaq” with publication date: June 07, 2019.
Since February 1, 2019, it had 0 insider purchases, and 1 sale for $255,087 activity.
Investors sentiment decreased to 0.96 in 2019 Q1. Its down 0.01, from 0.97 in 2018Q4. It is negative, as 79 investors sold AAPL shares while 847 reduced holdings. 150 funds opened positions while 735 raised stakes. 2.60 billion shares or 8.28% less from 2.83 billion shares in 2018Q4 were reported. Strs Ohio accumulated 2.96% or 3.43 million shares. Pictet Retail Bank Tru Limited invested 2.23% of its portfolio in Apple Inc. (NASDAQ:AAPL). Reik & Company Ltd Company stated it has 0.3% in Apple Inc. (NASDAQ:AAPL). 40,065 are held by Rench Wealth Mgmt. Td Cap Limited Company holds 5,089 shares. Quadrant Mngmt Limited Liability Com reported 29,783 shares. Consulate stated it has 2.66% of its portfolio in Apple Inc. (NASDAQ:AAPL). Main Street Research Ltd Co reported 58,399 shares stake. The Florida-based American Asset Inc has invested 1.86% in Apple Inc. (NASDAQ:AAPL). Capstone Ltd Liability Corp has invested 0.02% in Apple Inc. (NASDAQ:AAPL). Howland Capital Mgmt Limited Co invested 0.6% of its portfolio in Apple Inc. (NASDAQ:AAPL). Martin Investment Management Ltd Liability holds 5.47% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 110,574 shares. Nikko Asset Management Americas holds 1.06M shares or 5.31% of its portfolio. 1,674 were reported by Lynch And Assocs In. Gabelli Funds Limited holds 292,410 shares.
Since January 23, 2019, it had 0 buys, and 2 selling transactions for $4.45 million activity. $3.44 million worth of Sage Therapeutics, Inc. (NASDAQ:SAGE) was sold by Kanes Stephen.
More notable recent Sage Therapeutics, Inc. (NASDAQ:SAGE) news were published by: Nasdaq.com which released: “Discover Financial’s Payment Brand Ties Up With Sage Pay – Nasdaq” on May 29, 2019, also Benzinga.com with their article: “Benzinga’s Top Upgrades, Downgrades For May 23, 2019 – Benzinga” published on May 23, 2019, Seekingalpha.com published: “Wall Street Brunch – Seeking Alpha” on June 09, 2019. More interesting news about Sage Therapeutics, Inc. (NASDAQ:SAGE) were released by: Nasdaq.com and their article: “National MI Now Integrated with Blue Sage – Nasdaq” published on June 10, 2019 as well as Finance.Yahoo.com‘s news article titled: “Hereâ€™s What Hedge Funds Think About Herbalife Nutrition Ltd. (HLF) – Yahoo Finance” with publication date: June 10, 2019.
University Of Notre Dame Du Lac, which manages about $447.99M US Long portfolio, upped its stake in Alexion Pharmaceuticals Inc (NASDAQ:ALXN) by 21,513 shares to 61,518 shares, valued at $8.32 million in 2019Q1, according to the filing. It also increased its holding in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) by 30,825 shares in the quarter, for a total of 128,346 shares, and has risen its stake in Alphabet Inc.
Analysts await Sage Therapeutics, Inc. (NASDAQ:SAGE) to report earnings on August, 6. They expect $-3.32 EPS, down 822.22% or $2.96 from last year’s $-0.36 per share. After $-3.37 actual EPS reported by Sage Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -1.48% EPS growth.
Investors sentiment increased to 1.95 in 2019 Q1. Its up 0.88, from 1.07 in 2018Q4. It is positive, as 27 investors sold SAGE shares while 47 reduced holdings. 48 funds opened positions while 96 raised stakes. 53.89 million shares or 13.70% more from 47.40 million shares in 2018Q4 were reported. Element Capital Management Limited Com has 29,469 shares for 0.14% of their portfolio. Sg Americas Limited Liability Com has invested 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE). Citigroup has invested 0.01% in Sage Therapeutics, Inc. (NASDAQ:SAGE). M&R Mngmt reported 0.01% stake. Brinker Incorporated stated it has 6,771 shares. State Of New Jersey Common Pension Fund D holds 15,000 shares. Frontier Cap Commerce Lc has invested 0.29% in Sage Therapeutics, Inc. (NASDAQ:SAGE). Tocqueville Asset Management Ltd Partnership invested 0.13% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Janney Mngmt Ltd Liability Corp reported 0.03% stake. Reliance Trust Of Delaware stated it has 0.04% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Profund Advisors Llc, a Maryland-based fund reported 13,993 shares. Credit Suisse Ag holds 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE) or 28,873 shares. Fiera Cap has invested 0.19% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Moreover, State Street has 0.01% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 1.05M shares. Verition Fund stated it has 0.01% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.